Insomnia Therapeutics Market Analysis By Treatment Type [Devices, Drugs (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists)], By Sales Channel, And Segment Forecasts, 2014 - 2025
This report can be delivered to the clients within 48 hours
The global insomnia therapeutics market is expected to reach USD 3.45billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by thepresence of patented molecules, potential clinical pipeline candidates, rising stress level,and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia &awareness about this conditionand availability of safer drugs are anticipated to fuel revenue growth.
Insomnia is estimated to affect approximately 35% of the global population. Differentpatternsof the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings&awakening too early with trouble sleepingagain. Long-terminsomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this conditionmay lead to severe depression and nervous breakdown of the patient.
Factors influencing insomnia therapeutics market growth includerising stress level, presence of patented molecules in the market, potentialdrugs in clinical pipeline, introduction of technologically advanced medical devices, and growinggeriatric population.Growing awareness about the impact of sleep deprivation on everyday lifeis anticipated to increaseadoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.
Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market.Launch of Eisai’s Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According toUnited Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.
Further Key Findings From the Report Suggest:
The global insomnia therapeutics market is expected to reach USD 3.45billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by thepresence of patented molecules, potential clinical pipeline candidates, rising stress level,and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia &awareness about this conditionand availability of safer drugs are anticipated to fuel revenue growth.
Insomnia is estimated to affect approximately 35% of the global population. Differentpatternsof the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings&awakening too early with trouble sleepingagain. Long-terminsomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this conditionmay lead to severe depression and nervous breakdown of the patient.
Factors influencing insomnia therapeutics market growth includerising stress level, presence of patented molecules in the market, potentialdrugs in clinical pipeline, introduction of technologically advanced medical devices, and growinggeriatric population.Growing awareness about the impact of sleep deprivation on everyday lifeis anticipated to increaseadoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.
Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market.Launch of Eisai’s Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According toUnited Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.
Further Key Findings From the Report Suggest:
- North America held majority of the share in 2016 due to increase inawareness about diseases, growing geriatricpopulation, and high adoption of therapeutics for treatment.
- The U.S. dominated North America owing to the presence of largest sleep-deprived population and use of patented drugs for treatment.
- Japan is the second largest market after the U.S. Asia Pacific is expected to be the fastest growingmarket due to the presence ofemerging economies like China & India and launch of new drugs.
- Some of the key players are Takeda Pharmaceutical Co. Ltd.; Vanda Pharmaceuticals; Merck & Co, Inc.;Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N. V.; Sumitomo Dainippon Pharma Co., Ltd.; Sanofi; Paratek Pharmaceuticals;and Ebb Therapeutics.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s Internal Database
1.2 Primary Research:
1.2.1 List of primary sources include:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 INSOMNIA THERAPEUTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Technological advances in medical devices for insomnia.
3.1.1.2 Presence of potential clinical pipeline candidates for insomnia.
3.1.1.3 Rising stress levels and changing dynamics.
3.1.2 Market restraint analysis
3.1.2.1 Lower diagnosis rate, low treatment rate and high number of dis-satisfied patients.
3.1.2.2 Declining revenues with the expiry of branded drugs.
3.2 Insomnia Therapeutics Market - SWOT Analysis, by Factor (political & legal, economic and technological)
3.3 Industry Analysis - Porter’s
CHAPTER 4 INSOMNIA THERAPEUTICS MARKET: TREATMENT TYPE ESTIMATES & TREND ANALYSIS
4.1 Global Insomnia Therapeutics Market: Treatment Type Analysis
4.2 Drugs
4.2.1 Drugs treatment type market estimates and forecasts, 2014 - 2025 (USD Million)
4.3 Devices
4.3.1 Devices treatment type market estimates and forecasts, 2014 - 2025 (USD Million)
CHAPTER 5 INSOMNIA THERAPEUTICS: SALES CHANNEL TYPE ESTIMATES & TREND ANALYSIS
5.1 Global Insomnia Therapeutics Market: Sales Channel Type Analysis
5.2 Prescription
5.2.1 Prescription sales channel segment market estimates and forecasts, 2014 - 2025 (USD Million)
5.3 Over-the-Counter (OTC)
5.3.1 Over-the-Counter (OTC) sales channel segment market estimates and forecasts, 2014 - 2025 (USD Million)
CHAPTER 6 INSOMNIA THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TREATMENT TYPE & SALES CHANNEL
6.1 Global Insomnia Therapeutics Market Share, by Region, 2015 & 2025
6.2 North America
6.2.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.2.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million
6.2.3 U.S.
6.2.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.2.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.2.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.3.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.3.4 UK
6.3.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.3.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.4.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.4.4 China
6.4.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.4.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.5.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.5.3.1 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.5.4 Mexico
6.5.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.5.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.6.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.6.3 South Africa
6.2.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.2.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Takeda Pharmaceutical Company Ltd.
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Vanda Pharmaceuticals Inc.
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Merck & Co.
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Mylan N.V.
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Pfizer Inc.
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Teva Pharmaceutical Industries Ltd.
7.1.6.1 Company overview
7.1.6.2 Financial performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic initiatives
7.1.7 Sumitomo Dainippon Pharma Co., Ltd.
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Sanofi S.A.
7.1.8.1 Company overview
7.1.8.2 Financial performance
7.1.8.3 Product Benchmarking
7.1.8.4 Strategic initiatives
7.1.9 Paratek Pharmaceuticals, Inc.
7.1.9.1 Company overview
7.1.9.2 Financial performance
7.1.9.3 Product Benchmarking
7.1.9.4 Strategic initiatives
7.1.10 Ebb Therapeutics.
7.1.10.1 Company overview
7.1.10.2 Product Benchmarking
7.1.10.3 Strategic initiatives
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s Internal Database
1.2 Primary Research:
1.2.1 List of primary sources include:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 INSOMNIA THERAPEUTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Technological advances in medical devices for insomnia.
3.1.1.2 Presence of potential clinical pipeline candidates for insomnia.
3.1.1.3 Rising stress levels and changing dynamics.
3.1.2 Market restraint analysis
3.1.2.1 Lower diagnosis rate, low treatment rate and high number of dis-satisfied patients.
3.1.2.2 Declining revenues with the expiry of branded drugs.
3.2 Insomnia Therapeutics Market - SWOT Analysis, by Factor (political & legal, economic and technological)
3.3 Industry Analysis - Porter’s
CHAPTER 4 INSOMNIA THERAPEUTICS MARKET: TREATMENT TYPE ESTIMATES & TREND ANALYSIS
4.1 Global Insomnia Therapeutics Market: Treatment Type Analysis
4.2 Drugs
4.2.1 Drugs treatment type market estimates and forecasts, 2014 - 2025 (USD Million)
4.3 Devices
4.3.1 Devices treatment type market estimates and forecasts, 2014 - 2025 (USD Million)
CHAPTER 5 INSOMNIA THERAPEUTICS: SALES CHANNEL TYPE ESTIMATES & TREND ANALYSIS
5.1 Global Insomnia Therapeutics Market: Sales Channel Type Analysis
5.2 Prescription
5.2.1 Prescription sales channel segment market estimates and forecasts, 2014 - 2025 (USD Million)
5.3 Over-the-Counter (OTC)
5.3.1 Over-the-Counter (OTC) sales channel segment market estimates and forecasts, 2014 - 2025 (USD Million)
CHAPTER 6 INSOMNIA THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TREATMENT TYPE & SALES CHANNEL
6.1 Global Insomnia Therapeutics Market Share, by Region, 2015 & 2025
6.2 North America
6.2.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.2.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million
6.2.3 U.S.
6.2.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.2.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.2.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.3.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.3.4 UK
6.3.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.3.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.4.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.4.4 China
6.4.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.4.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.5.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.5.3.1 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.5.4 Mexico
6.5.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.5.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.6.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
6.6.3 South Africa
6.2.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
6.2.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Takeda Pharmaceutical Company Ltd.
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Vanda Pharmaceuticals Inc.
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Merck & Co.
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Mylan N.V.
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Pfizer Inc.
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Teva Pharmaceutical Industries Ltd.
7.1.6.1 Company overview
7.1.6.2 Financial performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic initiatives
7.1.7 Sumitomo Dainippon Pharma Co., Ltd.
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Sanofi S.A.
7.1.8.1 Company overview
7.1.8.2 Financial performance
7.1.8.3 Product Benchmarking
7.1.8.4 Strategic initiatives
7.1.9 Paratek Pharmaceuticals, Inc.
7.1.9.1 Company overview
7.1.9.2 Financial performance
7.1.9.3 Product Benchmarking
7.1.9.4 Strategic initiatives
7.1.10 Ebb Therapeutics.
7.1.10.1 Company overview
7.1.10.2 Product Benchmarking
7.1.10.3 Strategic initiatives
LIST OF TABLES
TABLE 1 Global insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 2 Global insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 3 North America insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 4 North America insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 5 U.S. insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 6 U.S. insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 7 Canada insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 8 Canada insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 9 Latin America insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 10 Latin America insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 11 Mexico insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 12 Mexico insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 13 Brazil insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 14 Brazil insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 15 Europe insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 16 Europe insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 17 U.K. insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 18 U.K. insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 19 Germany insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 20 Germany insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 21 Asia Pacific insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 22 Asia Pacific insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 23 Japan insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 24 Japan insomnia therapeutics market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 25 China insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 26 China insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 27 MEA insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 28 MEA insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 29 South Africa insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 30 South Africa insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 1 Global insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 2 Global insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 3 North America insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 4 North America insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 5 U.S. insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 6 U.S. insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 7 Canada insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 8 Canada insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 9 Latin America insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 10 Latin America insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 11 Mexico insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 12 Mexico insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 13 Brazil insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 14 Brazil insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 15 Europe insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 16 Europe insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 17 U.K. insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 18 U.K. insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 19 Germany insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 20 Germany insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 21 Asia Pacific insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 22 Asia Pacific insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 23 Japan insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 24 Japan insomnia therapeutics market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 25 China insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 26 China insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 27 MEA insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 28 MEA insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
TABLE 29 South Africa insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
TABLE 30 South Africa insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market summary
FIG. 5 Market trends & outlook
FIG. 6 Market segmentation & scope
FIG. 7 Market driver relevance analysis (Current & future impact)
FIG. 8 Market restraint relevance analysis (Current & future impact)
FIG. 9 Key opportunity priorities
FIG. 10 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 11 Porter’s Five Forces Analysis
FIG. 12 Global insomnia therapeutics market, Heat map analysis
FIG. 13 Global insomnia therapeutics market treatment type outlook & key takeaways
FIG. 14 Global insomnia therapeutics market drugs segment outlook & key takeaways
FIG. 15 Global insomnia therapeutics market devices segment outlook & key takeaways
FIG. 16 Global insomnia therapeutics market: sales channel type outlook & key takeaways
FIG. 17 Global insomnia therapeutics market, regional outlook & key takeaways 2014 - 2025
FIG. 18 North America insomnia therapeutics estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 19 U.S. insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 20 Canada insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 21 Europe insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 22 Germany insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 23 U.K. insomnia therapeutics estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 24 Asia Pacific insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 25 China insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 26 Japan insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 27 Latin America insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 28 Brazil insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 29 Mexico insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 30 MEA insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 31 South Africa insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market summary
FIG. 5 Market trends & outlook
FIG. 6 Market segmentation & scope
FIG. 7 Market driver relevance analysis (Current & future impact)
FIG. 8 Market restraint relevance analysis (Current & future impact)
FIG. 9 Key opportunity priorities
FIG. 10 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 11 Porter’s Five Forces Analysis
FIG. 12 Global insomnia therapeutics market, Heat map analysis
FIG. 13 Global insomnia therapeutics market treatment type outlook & key takeaways
FIG. 14 Global insomnia therapeutics market drugs segment outlook & key takeaways
FIG. 15 Global insomnia therapeutics market devices segment outlook & key takeaways
FIG. 16 Global insomnia therapeutics market: sales channel type outlook & key takeaways
FIG. 17 Global insomnia therapeutics market, regional outlook & key takeaways 2014 - 2025
FIG. 18 North America insomnia therapeutics estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 19 U.S. insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 20 Canada insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 21 Europe insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 22 Germany insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 23 U.K. insomnia therapeutics estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 24 Asia Pacific insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 25 China insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 26 Japan insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 27 Latin America insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 28 Brazil insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 29 Mexico insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 30 MEA insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 31 South Africa insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
